Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Notice of Intent to issue a Sole Source Award to generate and optimize high-affinity nucleic acid aptamers capable of semi-quantitative detection of TFV-DP and/or TFV for use in both plate-based assays and POC platforms.

Closed
75D30126R73457Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
Aeronautics and Spaceflight Systems Engineering Support Services (ASSESS) IIThe Aeronautics and Spaceflight Systems Engineering Support Services (ASSESS) II contract focuses on providing research, technology development, and engineering support to advance NASA’s aircraft and spaceflight system missions. This contract covers a broad range of activities including scientific research, engineering design and analysis, advancing technology readiness levels, managing and implementing technology programs, conducting tests and operations, and supporting program and project management efforts. The work aims to adapt and enhance capabilities to meet evolving NASA mission requirements, ensuring continued innovation and technical progress in aeronautics and spaceflight systems. The contract is forecasted to be performed primarily at Moffett Field and falls under the NAICS code 541715, which relates to research and development services. While details about set-aside status are yet to be determined, the contract offers opportunities for various types of organizations to participate. Points of contact for the contract are Mary E. Livingston and Robert E. Watts, who serve as the main liaison and small business specialist respectively. This contract underscores NASA’s commitment to advancing scientific and engineering frontiers through comprehensive support of aeronautics and spaceflight system development.
Ames Research Center

POSTED

in almost 3 years

DEADLINE

N/A

AI Contract Overview

Show more

The Centers for Disease Control and Prevention (CDC) Division of HIV Prevention intends to issue a sole source fixed-price contract to the University of North Carolina at Chapel Hill's Department of Chemistry. The purpose of this contract is to generate and optimize high-affinity nucleic acid aptamers that can semi-quantitatively detect TFV-DP and/or TFV. These aptamers will be used in both plate-based assays and point-of-care platforms. This contract is being awarded under FAR 12.102-1, allowing negotiation with a single source due to UNC's unique qualifications, including its role as co-inventor of a previously-developed FTC aptamer critical to antiretroviral detection research and the compatibility of its methodologies with the CDC’s existing assay development. UNC is considered the only source capable of meeting the technical requirements and timeline necessary for this work, as switching to another vendor would disrupt progress by necessitating a complete redo of the optimization process and would not align with current aptamers for emtricitabine detection. This notice is not a solicitation for competitive bids, though the CDC will consider any responses received within 15 days of issuance for the purpose of evaluating whether to proceed with a competitive procurement. Responses should be submitted by June 2, 2026, and any decision not to complete the contract based on received input remains at the government’s discretion. The contract aligns with NAICS code 541715 for Medical Research and Development Laboratories or Services and will be performed primarily in Chapel Hill, North Carolina.

General Info

CDC awards sole source contract to UNC for developing aptamers detecting TFV-DP/TFV in assays.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition Services

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) View NAICS

Place of Performance

Chapel Hill, NC, 27599, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts2 people available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
Office AddressATLANTA, GA, 30333, USA

Full Description

Show more

The Centers for Disease Control and Prevention Division of HIV Prevention (DHP)/Laboratory Branch intends to award a sole source Firm-fixed-price purchase order to the University of North Carolina at Chapel Hill, Department of Chemistry to generate and optimize high-affinity nucleic acid aptamers capable of semi-quantitative detection of TFV-DP and/or TFV for use in both plate-based assays and POC platforms. This contract action is for commercial services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102-1. NAICS 541715 - Medical Research and Development Laboratories or Services (except Biotechnology and Nanotechnology Research and Development). UNC was identified as uniquely qualified due to its role as a co-inventor of the FTC aptamer previously developed for ARV detection research, and established methodologies compatible with CDC’s current assay development efforts. UNC is the only source reasonably available capable of performing the required work within the required timeframe and technical specifications.  Changing to another vendor’s aptamer would severely impact the CDC’s progress in this area, requiring a start over of the entire process of optimization and would not be compatible with the already developed, existing aptamer detecting emtricitabine. This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government.  A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to the contract specialist at email zvm0@cdc.gov by 06/02/2026.